UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Paediatric respiratory reviews, ISSN 1526-0542, 09/2018, Volume 28, pp. 68 - 79
Hydroxychloroquine | Medication side effects | Interstitial lung disease in children (chILD) | Prednisolone | Azithromycin | Pulse methylprednisolone | Respiratory System | Pediatrics | Life Sciences & Biomedicine | Science & Technology | Prednisolone - adverse effects | Off-Label Use | Humans | Methylprednisolone - adverse effects | Hydroxychloroquine - adverse effects | Cyclophosphamide - adverse effects | Lung Diseases, Interstitial - drug therapy | Granulocyte-Macrophage Colony-Stimulating Factor - adverse effects | Azithromycin - adverse effects | Methotrexate - adverse effects | Antirheumatic Agents - adverse effects | Immunosuppressive Agents - adverse effects | Anti-Bacterial Agents - adverse effects | Child | Glucocorticoids - adverse effects | Rituximab - adverse effects | Complications and side effects | Corticosteroids | Drugs and youth | Lung diseases | Children's hospitals | Children | Drug therapy | Methylprednisolone | Diseases | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 01/2015, Volume 162, Issue 1, pp. 18 - 26
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glucocorticoids - therapeutic use | Prospective Studies | Kidney - pathology | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Lupus Nephritis - drug therapy | Male | Methylprednisolone - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Adult | Female | Drug Therapy, Combination | Glucocorticoids - adverse effects | Lupus Nephritis - pathology | Prednisone - adverse effects | Tacrolimus - adverse effects | Remission Induction | Mycophenolic Acid - adverse effects | Tacrolimus - therapeutic use | Pilot Projects | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Biopsy | Adolescent | Immunosuppressive Agents - adverse effects | Aged | Prednisone - therapeutic use | Lupus | Complications and side effects | Drug targeting | Nephritis | Drug therapy | Methods | Drugs | Clinical trials | Kidney diseases | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of medicine, ISSN 0002-9343, 2014, Volume 127, Issue 10, pp. 931 - 932
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Acetaminophen - adverse effects | Dacarbazine - adverse effects | Methylprednisolone - therapeutic use | Humans | Middle Aged | Dexamethasone - adverse effects | Male | Antineoplastic Agents - therapeutic use | Wound Healing | Anticonvulsants - adverse effects | Piracetam - therapeutic use | Stevens-Johnson Syndrome - therapy | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Antiemetics - adverse effects | Oxycodone - therapeutic use | Stevens-Johnson Syndrome - etiology | Anticonvulsants - therapeutic use | gamma-Globulins - therapeutic use | Analgesics, Opioid - therapeutic use | Stevens-Johnson Syndrome - diagnosis | Dexamethasone - therapeutic use | Glioblastoma - pathology | Piracetam - analogs & derivatives | Glioblastoma - complications | Glioblastoma - drug therapy | gamma-Globulins - administration & dosage | Dacarbazine - therapeutic use | Piracetam - adverse effects | Erythema - chemically induced | Analgesics, Opioid - adverse effects | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Erythema - diagnosis | Dacarbazine - analogs & derivatives | Oxycodone - adverse effects | Acetaminophen - therapeutic use | Proton Pump Inhibitors - adverse effects | Omeprazole - therapeutic use | Immunologic Factors - administration & dosage | Omeprazole - adverse effects | Proton Pump Inhibitors - therapeutic use | Piperidines - therapeutic use | Quinazolines - therapeutic use | Piperidines - adverse effects | Quinazolines - adverse effects | Drug Combinations | Immunologic Factors - therapeutic use | Methylprednisolone - administration & dosage | Medicine, Experimental | Toxic epidermal necrolysis | Medical research | Research | Skin diseases | Drug delivery systems | Medical treatment | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 01/2015, Volume 56, Issue 1, pp. 57 - 64
transplant | Lymphomas | B cells | chemotherapy | immunotherapy | Chemotherapy | Immunotherapy | Transplant | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - therapeutic use | Prognosis | Methylprednisolone - therapeutic use | Podophyllotoxin - adverse effects | Cytarabine - therapeutic use | Humans | Middle Aged | Podophyllotoxin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Methylprednisolone - adverse effects | Consolidation Chemotherapy | Cytarabine - adverse effects | Melphalan - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Carmustine - therapeutic use | Neoplasm Metastasis | Melphalan - adverse effects | Adult | Female | Carmustine - adverse effects | Lymphoma, B-Cell - drug therapy | Etoposide - adverse effects | Lymphoma, B-Cell - mortality | Prednisone - adverse effects | Etoposide - therapeutic use | Treatment Outcome | Disease Progression | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Cisplatin - adverse effects | Vincristine - adverse effects | Neoplasm Staging | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 3, pp. 211 - 220
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Glucocorticoids - therapeutic use | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Methylprednisolone - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Incidence | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - mortality | Female | Drug Therapy, Combination | Glucocorticoids - adverse effects | Antibodies, Monoclonal, Murine-Derived | Glomerular Filtration Rate | Kidney Diseases - drug therapy | Rituximab | Kidney Diseases - mortality | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | B-Lymphocytes - drug effects | Intention to Treat Analysis | Immunosuppressive Agents - adverse effects | Aged | Infusions, Intravenous | Cyclophosphamide | Vasculitis | Research | Comparative analysis | Drug therapy | Clinical trials | Medical treatment | Mortality | Regulatory approval | Index Medicus | Abridged Index Medicus | Urologi och njurmedicin | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Urology and Nephrology
Journal Article
Regional anesthesia and pain medicine, ISSN 1098-7339, 01/2018, Volume 43, Issue 1, pp. 84 - 91
Life Sciences & Biomedicine | Anesthesiology | Science & Technology | Arthralgia - etiology | Prospective Studies | Betamethasone - administration & dosage | United States | Humans | Middle Aged | Male | Methylprednisolone - adverse effects | Arthralgia - physiopathology | Knee Joint - innervation | Knee Joint - surgery | Osteoarthritis, Knee - complications | Time Factors | Female | Denervation - adverse effects | Catheter Ablation - adverse effects | Betamethasone - adverse effects | Triamcinolone Acetonide - administration & dosage | Analgesics - therapeutic use | Denervation - methods | Methylprednisolone Acetate | Knee Joint - drug effects | Osteoarthritis, Knee - diagnosis | Treatment Outcome | Arthralgia - diagnosis | Combined Modality Therapy | Osteoarthritis, Knee - therapy | Triamcinolone Acetonide - adverse effects | Methylprednisolone - analogs & derivatives | Cross-Over Studies | Adrenal Cortex Hormones - adverse effects | Injections, Intra-Articular | Aged | Osteoarthritis, Knee - physiopathology | Pain Measurement | Arthralgia - therapy | Adrenal Cortex Hormones - administration & dosage | Methylprednisolone - administration & dosage | Knee pain | Complications and side effects | Care and treatment | Corticosteroids | Patient outcomes | Causes of | Radiofrequency ablation | Dosage and administration | Comparative analysis | Osteoarthritis | Methods | Index Medicus | Original | Chronic and Interventional Pain
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2014, Volume 311, Issue 17, pp. 1750 - 1759
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Prednisolone - adverse effects | Prednisolone - administration & dosage | Double-Blind Method | Administration, Oral | Humans | Infant | Male | Methylprednisolone - adverse effects | Treatment Outcome | Biliary Atresia - drug therapy | Adrenal Cortex Hormones - adverse effects | Bilirubin - blood | Portoenterostomy, Hepatic | Biliary Atresia - surgery | Survival Analysis | Drainage - methods | Female | Infusions, Intravenous | Adrenal Cortex Hormones - administration & dosage | Methylprednisolone - administration & dosage | Biliary atresia | Care and treatment | Corticosteroids | Surgery | Dosage and administration | Research | Health aspects | Liver diseases | Drug therapy | Medical treatment | Childrens health | Steroids | Index Medicus | Abridged Index Medicus
Journal Article
American journal of kidney diseases, ISSN 0272-6386, 2005, Volume 45, Issue 3, pp. 502 - 509
chemotherapy | Mortality | bone marrow transplantation | Bone marrow transplantation | Chemotherapy | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Recurrence | Postoperative Complications - etiology | Methylprednisolone - therapeutic use | Hematologic Neoplasms - mortality | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Methylprednisolone - adverse effects | Methotrexate - therapeutic use | Postoperative Complications - mortality | Cyclophosphamide - adverse effects | Whole-Body Irradiation - adverse effects | Incidence | Patient Selection | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Transplantation Conditioning - adverse effects | Retrospective Studies | Transplantation Conditioning - methods | Acute Kidney Injury - etiology | Transplantation, Homologous - adverse effects | Busulfan - adverse effects | Comorbidity | Vidarabine - adverse effects | Postoperative Complications - therapy | Renal Dialysis - statistics & numerical data | Postoperative Complications - epidemiology | Vidarabine - analogs & derivatives | Hematologic Neoplasms - surgery | Cyclosporine - therapeutic use | Methotrexate - adverse effects | Mycophenolic Acid - adverse effects | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Graft vs Host Disease - drug therapy | Cyclosporine - adverse effects | Adolescent | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Acute Kidney Injury - therapy | Aged | Acute Kidney Injury - epidemiology | Cohort Studies | Index Medicus
Journal Article
BMC musculoskeletal disorders, ISSN 1471-2474, 02/2019, Volume 20, Issue 1, pp. 61 - 61
Knee | Opioid | Multimodal | Primary arthroplasty | Pain management | Life Sciences & Biomedicine | Orthopedics | Rheumatology | Science & Technology | Adrenergic Agonists - administration & dosage | Pain, Postoperative - etiology | Glucocorticoids - administration & dosage | Prospective Studies | Arthroplasty, Replacement, Knee - adverse effects | Ropivacaine - administration & dosage | Humans | Middle Aged | Epinephrine - administration & dosage | Male | Methylprednisolone - adverse effects | Epinephrine - adverse effects | Time Factors | Anesthetics, Local - adverse effects | Pain Management - adverse effects | Aged, 80 and over | Female | Anesthetics, Local - administration & dosage | Glucocorticoids - adverse effects | Japan | Pain Management - methods | Treatment Outcome | Ropivacaine - adverse effects | Pain, Postoperative - prevention & control | Injections | Adrenergic Agonists - adverse effects | Pain, Postoperative - diagnosis | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Aged | Pain Measurement | Drug Combinations | Methylprednisolone - administration & dosage | Usage | Care and treatment | Safety and security measures | Pain | Health aspects | Methods | Epinephrine | Heart failure | Postoperative period | Intravenous administration | Antiinflammatory agents | Narcotics | Arthroplasty (knee) | Clinical trials | Ropivacaine | Inflammation | Injection | Joint surgery | Methylprednisolone | Patients | Catheters | Studies | Hospitals | Index Medicus
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 05/2018, Volume 5, Issue 5, pp. e190 - e200
Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - therapeutic use | Methylprednisolone - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Methylprednisolone - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Lymphoma, T-Cell, Peripheral - diagnostic imaging | Deoxycytidine - therapeutic use | Aged, 80 and over | Deoxycytidine - adverse effects | Female | Lymphoma, T-Cell, Peripheral - drug therapy | Prednisone - adverse effects | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Cisplatin - adverse effects | Vincristine - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Doxorubicin - adverse effects | Prednisone - therapeutic use | Index Medicus
Journal Article